Tonix Pharmaceuticals Holding (TNXP) Equity Ratio (2023 - 2025)
Historic Equity Ratio for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to 0.92.
- Tonix Pharmaceuticals Holding's Equity Ratio rose 1720.0% to 0.92 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.92, marking a year-over-year increase of 1720.0%. This contributed to the annual value of 0.86 for FY2024, which is 2540.43% up from last year.
- As of Q3 2025, Tonix Pharmaceuticals Holding's Equity Ratio stood at 0.92, which was up 1720.0% from 0.9 recorded in Q2 2025.
- Over the past 5 years, Tonix Pharmaceuticals Holding's Equity Ratio peaked at 0.94 during Q1 2025, and registered a low of 0.6 during Q2 2024.
- Its 3-year average for Equity Ratio is 0.83, with a median of 0.87 in 2023.
- As far as peak fluctuations go, Tonix Pharmaceuticals Holding's Equity Ratio plummeted by 3189.87% in 2024, and later soared by 4973.48% in 2025.
- Over the past 3 years, Tonix Pharmaceuticals Holding's Equity Ratio (Quarter) stood at 0.68 in 2023, then grew by 25.4% to 0.86 in 2024, then increased by 6.87% to 0.92 in 2025.
- Its last three reported values are 0.92 in Q3 2025, 0.9 for Q2 2025, and 0.94 during Q1 2025.